Clinical Trial Update: The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial [Phase 4]

View source ↗

Summary

The POPCORN Phase 4 trial evaluating perioperative colchicine to reduce negative events in patients with coronary artery disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING